Literature DB >> 31931911

Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort.

A Z Soh1, C B E Chee2, Y-T Wang2, J-M Yuan3, W-P Koh4.   

Abstract

SETTING: Although diabetes (DM) and low body mass index (BMI) are established risk factors for active tuberculosis (TB), the joint effect of type 2 diabetes (T2D) and BMI is unclear.
DESIGN: A prospective cohort of 63,257 adults aged 45-74 years were recruited from 1993 to 1998 in Singapore. Active TB cases were identified via linkage with the National TB Registry up to December 2014. Cox regression models were used to estimate the hazard ratios (HRs) and 95% confidence intervals (CIs) for the relations of T2D and BMI, independently and jointly, with TB risk.
RESULTS: T2D was associated with increased TB risk (HR 2.31, 95% CI 1.93-2.78). Conversely, BMI was inversely associated with TB risk: HR for underweight (BMI < 18.5 kg/m²) was 2.87 (95% CI 2.15-3.82) compared to obese (BMI ≥ 27.5 kg/m²) individuals. Compared to obese individuals without T2D, HR for active TB among underweight individuals with T2D was 8.30 (95% CI 4.43-15.54). There was no statistically significant interaction between BMI and T2D on TB risk (Pinteraction = 0.85).
CONCLUSION: Underweight and T2D are independent determinants for active TB. This has important public health implications in Asia where prevalence of tuberculous infection is high, and T2D occurs at lower levels of BMI.

Entities:  

Mesh:

Year:  2019        PMID: 31931911     DOI: 10.5588/ijtld.19.0094

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: a systematic review and meta-analysis.

Authors:  Qian Wu; Yang Liu; Yu-Bo Ma; Kui Liu; Song-Hua Chen
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

2.  Synergy between low BMI and hyperglycemia at baseline increases tuberculosis incidence among people living with HIV.

Authors:  Nang T T Kyaw; Ajay M V Kumar; Anthony D Harries; Srinath Satyanarayana; Nay L Oo; Matthew J Hayat; Kenneth G Castro; Matthew J Magee
Journal:  AIDS       Date:  2022-01-01       Impact factor: 4.177

3.  Hyperglycemia and dyslipidemia: Reduced HLA-DR expression in monocyte subpopulations from diabetes patients.

Authors:  Blanca I Restrepo; Marcel Twahirwa; Chinnaswamy Jagannath
Journal:  Hum Immunol       Date:  2020-12-08       Impact factor: 2.211

4.  Joint Associations of Multiple Lifestyle Factors With Risk of Active Tuberculosis in the Population: The Singapore Chinese Health Study.

Authors:  Huiqi Li; Cynthia B E Chee; Tingting Geng; An Pan; Woon Puay Koh
Journal:  Clin Infect Dis       Date:  2022-08-25       Impact factor: 20.999

5.  The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground.

Authors:  Anthony D Harries; Ajay M V Kumar; Srinath Satyanarayana; Pruthu Thekkur; Yan Lin; Riitta A Dlodlo; Mohammed Khogali; Rony Zachariah
Journal:  Trop Med Infect Dis       Date:  2020-04-16

6.  Body Mass Index, Diabetes, and Risk of Tuberculosis: A Retrospective Cohort Study.

Authors:  Hayoung Choi; Jung Eun Yoo; Kyungdo Han; Wonsuk Choi; Sang Youl Rhee; Hyun Lee; Dong Wook Shin
Journal:  Front Nutr       Date:  2021-12-01

7.  Attributable is preventable: Corrected and revised estimates of population attributable fraction of TB related to undernutrition in 30 high TB burden countries.

Authors:  Anurag Bhargava; Madhavi Bhargava; Andrea Beneditti; Anura Kurpad
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-03-08

8.  Association between body mass index and newly diagnosed drug-resistant pulmonary tuberculosis in Shandong, China from 2004 to 2019.

Authors:  Wan-Mei Song; Jing Guo; Ting-Ting Xu; Shi-Jin Li; Jin-Yue Liu; Ning-Ning Tao; Yao Liu; Qian-Yun Zhang; Si-Qi Liu; Qi-Qi An; Yi-Fan Li; Chun-Bao Yu; Ji-Hua Dong; Huai-Chen Li
Journal:  BMC Pulm Med       Date:  2021-12-06       Impact factor: 3.317

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.